Catalent 4Q Revenues: $532.2 million (+4%) 4Q Earnings: $58.1 million (earnings were $153.5 million 4Q15) FY Revenues: $1.9 billion (+1%) FY Earnings: $111.2 million (-47%) Comments: Revenue from the Softgel Technologies segment was $224.8 million for the quarter, up 1%. Revenue from the Drug Delivery Solutions segment was $238.2 million, an increase of 9%, primarily driven by increased volumes for fee-for-service development work and analytical testing in the U.S., and increased ...